These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7493430)

  • 1. Beta-cell function in hypopituitary adults before and during growth hormone treatment.
    Beshyah SA; Gelding SV; Andres C; Johnston DG; Gray IP
    Clin Sci (Lond); 1995 Sep; 89(3):321-8. PubMed ID: 7493430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperproinsulinaemia in impaired glucose tolerance.
    Krentz AJ; Clark PM; Cox L; Nattrass M
    Clin Sci (Lond); 1993 Jul; 85(1):97-100. PubMed ID: 8149702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.
    Beshyah SA; Henderson A; Niththyananthan R; Skinner E; Anyaoku V; Richmond W; Sharp P; Johnston DG
    J Clin Endocrinol Metab; 1995 Feb; 80(2):356-63. PubMed ID: 7852490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
    Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
    Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.
    Davies MJ; Rayman G; Gray IP; Day JL; Hales CN
    Diabet Med; 1993 May; 10(4):313-20. PubMed ID: 8508612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults.
    Beshyah SA; Shahi M; Skinner E; Sharp P; Foale R; Johnston DG
    Eur J Endocrinol; 1994 May; 130(5):451-8. PubMed ID: 8180671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.
    al-Shoumer KA; Beshyah SA; Niththyananthan R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):85-90. PubMed ID: 7889636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
    Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults.
    al-Shoumer KA; Anyaoku V; Richmond W; Johnston DG
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):153-9. PubMed ID: 9302387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis.
    Hamdi I; Green M; Shneerson JM; Palmer CR; Hales CN
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):21-6. PubMed ID: 8348704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
    Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
    Pfeifer M; Kanc K; Verhovec R; Kocijancic A
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
    Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
    Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.
    al-Shoumer KA; Gray R; Anyaoku V; Hughes C; Beshyah S; Richmond W; Johnston DG
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):795-802. PubMed ID: 9713570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Thomas E; Rutherford O; Page B; Murphy M; Johnston DG
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):179-89. PubMed ID: 7704962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
    Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. True insulin and intact proinsulin levels in acromegalic patients.
    Tavares EF; Dalbosco IS; Abucham J; Russo EM
    Eur J Endocrinol; 1996 May; 134(5):549-53. PubMed ID: 8664973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients.
    Kousta E; Chrisoulidou A; Lawrence NJ; Anyaoku V; Al-Shoumer KA; Johnston DG
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):17-24. PubMed ID: 10651749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.